In brief: Schizophrenia and the metabolic syndrome

In Brief

Schizophrenia and the metabolic syndrome

Results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study show that people with schizophrenia, especially women, are exceptionally vulnerable to the metabolic syndrome.

This set of health risks includes at least three of the following:

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »